Abe, Kohtaro <br/><br/>
Long-term inhibition of Rho-kinase ameliorates hypoxia-induced pulmonary hypertension in mice.  [electronic resource] 

 -  Journal of cardiovascular pharmacology  Dec 2006 
 - 280-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Standard No.: </label>10.1097/01.fjc.0000248244.64430.4a  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine--analogs & derivatives<br/>Animals<br/>Arterioles--drug effects<br/>Blotting, Western<br/>Disease Models, Animal<br/>Hypertension, Pulmonary--physiopathology<br/>Hypertrophy, Right Ventricular--physiopathology<br/>Hypoxia--physiopathology<br/>Intracellular Signaling Peptides and Proteins--antagonists & inhibitors<br/>Lung--blood supply<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Nitric Oxide Synthase Type III--deficiency<br/>Phosphorylation--drug effects<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Serine-Threonine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Time Factors<br/>Up-Regulation--drug effects<br/>rho-Associated Kinases